Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

A world-first clinical trial launched in Melbourne is being hailed as a "game-changer" for its potential to revolutionize the ...

Tresidder said his Melbourne-based firm has “a real focus” on biotech and life sciences. He sketched some of the ways brokers ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

Casemiro has had its trials and tribulations at Man Utd over the past two years but the Brazilian has enjoyed a renaissance ...

In a dynamic environment, an expert shares insights into potential AI applications in the clinical research setting at OCT ...

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

As the world begins to more heavily rely on artificial intelligence (AI), keeping people and their businesses in the know can ...

PYRUKYND Net Revenue of $8.7 Million in Q1; Cash, Cash Equivalents and Marketable Securities of $1.4 Billion as of March 31, 2025 - CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Agios ...

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...

A new scoping review reveals major inconsistencies in how plant-based diet diversity is defined, measured, and linked to ...

Pesticides, herbicides, insecticides, preservatives, toxic heavy metals like lead and mercury: Are micropoisons real—and dangerous? Experts reveal the truth.